Valuable feedback from newborn blood spot failsafe solution (NBSFS) survey
The PHE newborn blood spot (NBS) screening team has analysed results from its evaluation survey of the newborn blood spot failsafe solution.
Jamili Miah joined Public Health England in September 2013. Jamili worked for the Diabetic Eye Screening Programme in Birmingham for three years as a screener and disease grader. She then moved to London to join the NHS Newborn Blood Spot Screening Programme Team as Project Support. Her work has included supporting the national roll out of expanded screening and, implementing the new blood spot quality guidelines across all English newborn screening laboratories. In addition Jamili has recently also joined the Sickle Cell and Thalassaemia Screening Programme.
The PHE newborn blood spot (NBS) screening team has analysed results from its evaluation survey of the newborn blood spot failsafe solution.
New sickle cell and thalassaemia counselling knowledge and skills resource launched.
Kings College London provides a range of sickle cell and thalassaemia (SCT) study days each year. Unfortunately, due to the coronavirus (COVID-19) outbreak, the university and the NHS SCT Screening Programme have made a joint decision to defer all SCT …
The PHE Screening information for parents of babies suspected of having cystic fibrosis (CF) has been updated and published in accessible digital HTML format.
We have published an updated HTML version of the newborn blood spot sampling quick reference guide.
Register now for an SCT screening programme update or specialist counsellor update.
The NHS Sickle Cell and Thalassaemia (SCT) Screening Programme is offering 25 funded places on this year’s course at King’s College London.
Cathy Coppinger recently stepped down as manager of the NHS sickle cell and thalassaemia (SCT) screening programme to enjoy a well-deserved retirement. Her former colleagues pay tribute to her hard work.
We are working with the Sickle Cell Society to update the Sickle Cell Disease in Childhood: Standards and guidelines for clinical care. We want you to tell us your views.
Early access to sickle cell and thalassaemia screening is important in giving time to women and couples to consider their options. Performance varies across the country, so we are sharing some best practice tips and a new checklist tool.
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.